Institutional Ownership
Intellia Therapeutics Inc
CUSIP 45826J105COMNTLAQ1 2026
Institutional Holders
293
13F filers
Shares Held
98.19M
Aggregate institutional
Institutional Value
$1.24B
Q1 2026
Net New Holders
+4
51 new · 47 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions51
Increased129
Decreased62
Sold out47
Institutional Holders
293 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ark Investment Management LLC | 14.51M | $186.01M | +301.9K | Added |
| 2 | Blackrock, Inc. | 12.16M | $155.84M | +1.88M | Added |
| 3 | State Street Corp | 6.92M | $88.75M | +503.8K | Added |
| 4 | D. E. Shaw & Co., Inc. | 5.73M | $73.44M | +397.1K | Added |
| 5 | Two Sigma Investments, LP | 4.71M | $60.33M | +2.01M | Added |
| 6 | Regeneron Pharmaceuticals, Inc. | 3.70M | $47.47M | 0 | Held |
| 7 | Geode Capital Management, LLC | 2.85M | $36.56M | +155.3K | Added |
| 8 | Ubs Group AG | 2.69M | $34.48M | +1.83M | Added |
| 9 | Dimensional Fund Advisors LP | 2.32M | $29.71M | +386.3K | Added |
| 10 | Morgan Stanley | 2.08M | $26.68M | −246.5K | Reduced |
283 more institutional holders on Premium
See every fund holding Intellia Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders